Sinovac Biotech Ltd. (SVA) Lowered to "Sell" at TheStreet
A number of institutional investors have modified their holdings of the company. EQIS Capital Management raised its position in shares of Sinovac Biotech by 6,472.2% in the fourth quarter.
from Biotech News
0 Comments